145,289 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by Sculptor Capital LP

Sculptor Capital LP bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 145,289 shares of the company's stock, valued at approximately $5,085,000. Sculptor Capital LP owned 0.09% of Tempus AI as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TEM. EFG Asset Management North America Corp. bought a new position in Tempus AI during the 2nd quarter valued at about $1,333,000. ARK Investment Management LLC acquired a new position in shares of Tempus AI in the 2nd quarter valued at approximately $18,294,000. Northwestern University bought a new stake in Tempus AI during the 2nd quarter worth approximately $491,000. Alphabet Inc. acquired a new stake in Tempus AI during the 2nd quarter worth approximately $54,289,000. Finally, Pier Capital LLC bought a new position in Tempus AI in the second quarter valued at approximately $2,301,000.

Tempus AI Trading Up 3.7 %

Shares of TEM stock traded up $1.93 during mid-day trading on Friday, reaching $53.80. 541,666 shares of the stock traded hands, compared to its average volume of 1,214,295. The business has a fifty day moving average price of $49.38. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $77.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. On average, sell-side analysts predict that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on TEM shares. Stifel Nicolaus initiated coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a "buy" rating and a $45.00 target price on the stock. Piper Sandler initiated coverage on shares of Tempus AI in a report on Monday, August 12th. They set a "neutral" rating and a $40.00 target price for the company. William Blair assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an "outperform" rating on the stock. Loop Capital assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price objective for the company. Finally, Longbow Research initiated coverage on Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $48.00 target price on the stock. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, Tempus AI has an average rating of "Moderate Buy" and an average price target of $45.56.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.